C. Wu

564 total citations
11 papers, 435 citations indexed

About

C. Wu is a scholar working on Biotechnology, Oncology and Genetics. According to data from OpenAlex, C. Wu has authored 11 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biotechnology, 6 papers in Oncology and 4 papers in Genetics. Recurrent topics in C. Wu's work include Cancer Research and Treatments (8 papers), Virus-based gene therapy research (4 papers) and Peptidase Inhibition and Analysis (3 papers). C. Wu is often cited by papers focused on Cancer Research and Treatments (8 papers), Virus-based gene therapy research (4 papers) and Peptidase Inhibition and Analysis (3 papers). C. Wu collaborates with scholars based in United States, Netherlands and China. C. Wu's co-authors include Niramol Savaraj, Lynn G. Feun, M. Tien Kuo, Medhi Wangpaichitr, Min You, S. Spector, F. Moffat, John S. Bomalaski, Warren R. Sisson and George W. Elgart and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and British Journal of Cancer.

In The Last Decade

C. Wu

11 papers receiving 426 citations

Peers

C. Wu

BIOTE

MB

CR

GENET

ONCOL

Claudia Luckner‐Minden Germany

Alona Sarver Israel

Sonia Voiculescu United States

Tiago M. A. Carvalho Italy

Jin Gyoung Jung South Korea

Igor Monteze Ferreira Brazil

Dorothy Hardy United States

Frances F. Diehl United States

Iqbal Dulloo Singapore

Yair Pozniak Israel

Claudia Luckner‐Minden Germany

C. Wu

66 ×0.3

BIOTE

97 ×0.5

MB

62 ×0.4

CR

23 ×0.2

GENET

66 ×0.9

ONCOL

Citations per year, relative to C. Wu C. Wu (= 1×) peers Claudia Luckner‐Minden

Countries citing papers authored by C. Wu

Since Specialization

Citations

This map shows the geographic impact of C. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Wu more than expected).

Fields of papers citing papers by C. Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Wu. The network helps show where C. Wu may publish in the future.

Co-authorship network of co-authors of C. Wu

This figure shows the co-authorship network connecting the top 25 collaborators of C. Wu. A scholar is included among the top collaborators of C. Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Wu. C. Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Kandemır, Hasan, et al.. (2017). Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer. PubMed. 6(2). 35 indexed citations

2.

Wang, Fudi, et al.. (2016). Three metal complexes based on tetrazolyl ligands: Hydrothermal syntheses, crystal structures, and fluorescence properties. Russian Journal of Coordination Chemistry. 42(12). 789–796. 2 indexed citations

3.

Wu, C., et al.. (2012). 815 CHARACTERISTICS OF T CELL SUBSETS AND PROGRAMMED DEATH 1 EXPRESSION ON T CELLS IN HBV-RELATED HEPATOCELLULAR CARCINOMA (HCC). Journal of Hepatology. 56. S318–S319. 1 indexed citations

4.

Feun, Lynn G., Gail Walker, George W. Elgart, et al.. (2012). Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. British Journal of Cancer. 106(9). 1481–1485. 88 indexed citations

5.

You, Min, et al.. (2011). Determining argininosuccinate synthetase (ASS) expression in patients with melanoma treated with arginine depleting therapy.. Journal of Clinical Oncology. 29(15_suppl). 10627–10627. 1 indexed citations

6.

Savaraj, Niramol, Min You, C. Wu, et al.. (2010). Arginine Deprivation, Autophagy, Apoptosis (AAA) for the Treatment of Melanoma. Current Molecular Medicine. 10(4). 405–412. 87 indexed citations

7.

Feun, Lynn G., et al.. (2010). Final results of phase II trial of pegylated arginine deiminase (ADI-PEG20) in metastatic melanoma (MM).. Journal of Clinical Oncology. 28(15_suppl). 8528–8528. 8 indexed citations

8.

Feun, Lynn G., Min You, C. Wu, et al.. (2008). Arginine Deprivation as a Targeted Therapy for Cancer. Current Pharmaceutical Design. 14(11). 1049–1057. 184 indexed citations

9.

Feun, Lynn G., Niramol Savaraj, C. Wu, et al.. (2008). Clinical and pharmacologic study of ADI-PEG20 in hepatocellular carcinoma. Journal of Clinical Oncology. 26(15_suppl). 15584–15584. 2 indexed citations

10.

Feun, Lynn G., Niramol Savaraj, C. Wu, et al.. (2006). Phase II study of pegylated arginine deiminase (ADI-PEG20), a novel targeted therapy for melanoma. Journal of Clinical Oncology. 24(18_suppl). 8045–8045. 6 indexed citations

11.

Brouty‐Boyé, Danièle, Despina S. Kolonias, C. Wu, Niramol Savaraj, & Théodore J. Lampidis. (1995). Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: taxol and vinblastine modulate drug efflux.. PubMed. 55(8). 1633–8. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact